Swimming training improves the vasodilator effect of angiotensin-(1-7) in the aorta of spontaneously hypertensive rat

Journal of Applied Physiology

Volumn 111, Issue 5, 2011, Pages 1272-1277

  Silva, Denise M R ^a   Gomes Filho, Ary ^b   Olivon, Vania C ^c   Santos, Tassia M S ^d   Becker, Lenice K ^d,e   Santos, Robson A S ^c,e   Lemos, Virginia S ^c  

^a Estadual University of Minas Gerais (FUNEDI/UEMG)   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^e INCT Nanobiofar ^*  (Brazil)

Author keywords

Endothelial dysfunction; Hypertension; Mas receptor; Swimming training

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN I; ANGIOTENSIN I (1 7); ANGIOTENSIN I (1-7); G PROTEIN COUPLED RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; ONCOPROTEIN; PEPTIDE FRAGMENT; PROTO ONCOGENE PROTEINS C MAS 1; PROTO-ONCOGENE PROTEINS C-MAS-1; VASODILATOR AGENT;

ANIMAL; AORTA; ARTICLE; DRUG EFFECT; MALE; METABOLISM; MUSCLE ISOMETRIC CONTRACTION; PHYSIOLOGY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SWIMMING; VASCULAR ENDOTHELIUM; VASODILATATION; WISTAR RAT;

ACETYLCHOLINE; ANGIOTENSIN I; ANIMALS; AORTA; ENDOTHELIUM, VASCULAR; ISOMETRIC CONTRACTION; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS; RATS; RATS, INBRED SHR; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED; SWIMMING; VASODILATION; VASODILATOR AGENTS;

EID: 81355163726     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00034.2011     Document Type: Article

References (46)

1. Adams V, Linke A, Kränkel N, Erbs S, Gielen S, Möbius-Winkler S, Gummert JF, Mohr FW, Schuler G, Hambrecht R. Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in patients with coronary artery disease. Circulation 111: 555-562, 2005. (Pubitemid 40216482)
2. Benter IF, Ferrario CM, Morris M, Diz DI. Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 269: H313-H319, 1995.
3. Braith RW, Welch MA, Feigenbaum MS, Kluess HK, Pepine CJ. Neuroendocrine activation in heart failure is modified by endurance exercise training. J Am Coll Cardiol 34: 1170-1175, 1999. (Pubitemid 29500556)
4. Chappell MC. Emerging evidence for a functional Angiotensin-converting enzyme 2-Angiotensin-(1-7)-Mas receptor axis: more than regulation of blood pressure? Hypertension 50: 596-599, 2007. (Pubitemid 47442717)
5. DelliPizzi AM, Hilchey SD, Bell-Quilley CP. Natriuretic action of angiotensin(1-7). Br J Pharmacol 111: 1-3, 1994. (Pubitemid 24148696)
6. Ferreira AJ, Santos RA, Almeida AP. Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion. Hypertension 38: 665-668, 2001.
7. Ferreira AJ, Santos RA. Cardiovascular actions of angiotensin-(1-7). Braz J Med Biol Res 38: 499-507, 2005. (Pubitemid 40703878)
8. Ferreira PM, Alzamora AC, Santos RA, Campagnole-Santos MJ. Hemodynamic effect produced by microinjection of angiotensins at the caudal ventrolateral medulla of spontaneously hypertensive rats. Neuroscience 151: 1208-1216, 2008.
9. Feterik K, Smith L, Katusic ZS. Angiotensin-(1-7) causes endotheliumdependent relaxation in canine middle cerebral artery. Brain Res 873: 75-82, 2000. (Pubitemid 30468487)
10. Fraga-Silva RA, Pinheiro SV, Gonçalves AC, Alenina N, Bader M, Santos RA. The antithrombotic effect of angiotensin-(1-7) involves mas-mediated NO release from platelets. Mol Med 14: 28-35, 2008. (Pubitemid 351356883)
11. Freeman EJ, Chilson GM, Ferrario CM, Tallant EA. Angiotensin-(1-7) augments inhibits vascular smooth muscle cell growth. Hypertension 28: 104-108, 1996.
12. Gironacci MM, Adler-Graschinsky E, Peña C, Enero MA. Effects of angiotensin II and angiotensin-(1-7) on the release of [3H]norepinephrine from rat atria. Hypertension 24: 457-460, 1994. (Pubitemid 24296467)
13. Gironacci MM, Brosnihan KB, Ferrario CM, Gorzalczany S, Verrilli MA, Pascual M, Taira C, Peña C. Increased hypothalamic angiotensin-(1-7) levels in rats with aortic coarctation-induced hypertension. Peptides 28: 1580-1585, 2007. (Pubitemid 47247956)
14. Gomes-Filho A, Ferreira AJ, Santos SH, Neves SR, Silva Camargos ER, Becker LK, Belchior HA, Dias-Peixoto MF, Pinheiro SV, Santos RA. Selective increase of Angiotensin-(1-7) and its receptor in spontaneously hypertensive rat hearts subjected to physical training. Exp Physiol 93: 589-598, 2008. (Pubitemid 351595056)
15. Hayashi A, Kobayashi A, Takahashi R, Suzuki F, Nakagawa T, Kimotro K. Effects of voluntary running exercise on blood pressure and renin-angiotensin system in spontaneously hypertensive rats and normotensive Wistar-Kyoto rats. J Nutr Sci Vitaminol (Tokyo) 46: 165-170, 2000.
16. Kohara K, Brosnihan KB, Ferrario CM. Angiotensin(1-7) in the spontaneously hypertensive rat. Peptides 14: 883-891, 1993.
17. Kozlovski VI, Lomnicka M, Fedorowicz A, Chlopicki S. On the mechanism of coronary vasodilation induced by angiotensin-(1-7) in the isolated guinea pig heart. Basic Clin Pharmacol Toxicol 100: 361-365, 2007. (Pubitemid 46776383)
18. Kucharewicz I, Chabielska E, Pawlak D, Matys T, Rólkowski R, Buczko W. The antithrombotic effect of angiotensin-(1-7) closely resembles that of losartan. J Renin Angiotensin Aldosterone Syst 1: 268-272, 2000.
19. Le tran Y, Foster C. Angiotensin-(1-7) and the rat aorta: modulation by the endothelium. J Cardiovasc Pharmacol 30: 676-682, 1997. (Pubitemid 27524509)
20. Leal MC, Pinheiro SV, Ferreira AJ, Santos RA, Bordoni LS, Alenina N, Bader M, França LR. The role of angiotensin-(1-7) receptor Mas in spermatogenesis in mice and rats. J Anat 214: 736-743, 2009.
21. Lee RM, Lu C, Su LY, Gao YJ. Endothelium-dependent relaxation factor released by perivascular adipose tissue. J Hypertens 27: 782-790, 2009.
22. Lemos VS, Côrtes SF, Silva DM, Campagnole-Santos MJ, Santos RA. Angiotensin-(1-7) is involved in the endothelium-dependent modulation of phenylephrine-induced contraction in the aorta of mRen-2 transgenic rats. Br J Pharmacol 135: 1743-1748, 2002. (Pubitemid 38075539)
23. Lemos VS, Silva DM, Walther T, Alenina N, Bader M, Santos RA. The endothelium-dependent vasodilator effect of the nonpeptide Ang(1-7) mimic AVE 0991 is abolished in the aorta of mas-knockout mice. J Cardiovasc Pharmacol 46: 274-279, 2005. (Pubitemid 41262828)
24. Medeiros A, Oliveira EM, Gianolla R, Casarini DE, Negrão CE, Brum PC. Swimming training increases cardiac vagal activity and induces cardiac hypertrophy in rats. Braz J Med Biol Res 37: 1909-1917, 2004. (Pubitemid 40089945)
25. Minami N, Li Y, Guo Q, Kawamura T, Mori N, Nagasaka M, Ogawa M, Ito O, Kurosawa H, Kanazawa M, Kohzuki M. Effects of angiotensin-converting enzyme inhibitor and exercise training on exercise capacity and skeletal muscle. J Hypertens 25: 1241-1248, 2007. (Pubitemid 46918803)
26. Moltzer E, Verkuil AV, van Veghel R, Danser AH, van Esch JH. Effects of angiotensin metabolites in the coronary vascular bed of the spontaneously hypertensive rat: loss of angiotensin II type 2 receptormediated vasodilation. Hypertension 5: 516-522, 2010.
27. Muñoz MC, Giani JF, Dominici FP. Angiotensin-(1-7) stimulates the phosphorylation of Akt in rat extracardiac tissues in vivo via receptor Mas. Regul Pept 161: 1-7, 2010.
28. Neves LA, Averill DB, Ferrario CM, Chappell MC, Aschner JL, Walkup MP, Brosnihan KB. Characterization of angiotensin-(1-7) receptor subtype in mesenteric arteries. Peptides 24: 455-462, 2003. (Pubitemid 36561219)
29. Osei SY, Ahima RS, Minkes RK, Weaver JP, Khosla MC, Kadowitz PJ. Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds. Eur J Pharmacol 30: 35-42, 1993. (Pubitemid 23093402)
30. Pörsti I, Bara AT, Busse R, Hecker M. Release of oxide nitric by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br J Pharmacol 111: 652-654, 1994. (Pubitemid 24151646)
31. Ren Y, Garvin J, Carretero OA. Mechanism involved in bradykinininduced efferent arteriole dilation. Kidney Int 62: 544-549, 2002. (Pubitemid 34779766)
32. Sampaio WO, Souza dos Santos RA, Faria-Silva R, da Mata Machado LT, Schiffrin EL, Touyz RM. Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 49: 185-192, 2007. (Pubitemid 46360359)
33. Santiago NM, Guimarães PS, Sirvente RA, Oliveira LA, Irigoyen MC, Santos RA, Campagnole-Santos MJ. Lifetime overproduction of circulating Angiotensin-(1-7) attenuates deoxycorticosterone acetate-salt hypertension-induced cardiac dysfunction and remodeling. Hypertension 55: 889-896, 2010.
34. Santos RA, Campagnole-Santos MJ, Andrade SP. Angiotensin-(1-7): an update. Regul Pept 91: 45-62, 2000.
35. Santos RA, Silva ACE, Maric C, Silva DM, Machado RP, De Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, Walther T. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 100: 8258-8263, 2003. (Pubitemid 36842532)
36. Santos RAS, Frezard F, Ferreira AJ. Angiotensin-(1-7): blood, heart, and blood vessels. Curr Med Chem Cardiovasc Hematol Agents 3: 383-391, 2005.
37. Silva DM, Vianna HR, Cortes SF, Campagnole-Santos MJ, Santos RA, Lemos VS. Evidence for a new angiotensin-(1-7) receptor subtype in the aorta of Sprague-Dawley rats. Peptides 28: 702-707, 2007. (Pubitemid 46204993)
38. Straw WB, Ferrario CM, Tallant EA. Angiotensin-(1-7) reduces smooth muscle growth after vascular injury. Hypertension 33: 207-211, 1999. (Pubitemid 29065661)
39. Tallant EA, Diz DI, Ferrario CM. Antiproliferative actions of angiotensin-(1-7)in vascular muscle smooth. Hypertension 34: 950-957, 1999. (Pubitemid 29501329)
40. Trippodo NC, Frohlich ED. Similarities of genetic (spontaneous) hypertension. Man and rat. Circ Res 48: 309-319, 1981.
41. Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, Godbout K, Parsons T, Baronas E, Hsieh F, Acton S, Patane M, Nichols A, Tummino P. Hydrolysis of biological peptides by human angiotensinconverting enzyme-related carboxypeptidase. J Biol Chem 277: 14838-14843, 2002. (Pubitemid 34952556)
42. Wang Y, Qian C, Roks A, Westermann D, Schumacher SM, Escher F, Schoemaker R, Reudelhuber TL, van Gilst W, Schultheiss HP, Tschöpe C, Walther T. Circulating rather than cardiac angiotensin-(1-7) stimulates cardioprotection post myocardial infarction. Circ Heart Fail 3: 286-293, 2010.
43. Wessel N, Malberg H, Heringer-Walther S, Schultheiss HP, Walther T. The angiotensin-(1-7) receptor agonist AVE0991 dominates the circadian rhythm and baroreflex in spontaneously hypertensive rats. J Cardiovasc Pharmacol 49: 67-73, 2007.
44. Widdop RE, Sampey DB, Jarrott B. Cardiovascular effects of angiotensin-( 1-7) in conscious spontaneously hypertensive rats. Hypertension 34: 964-968, 1999. (Pubitemid 29501331)
45. Yamada K, Iyer SN, Chappell MC, Ganten D, Ferrario CM. Converting enzyme determines plasma clearance of angiotensin-(1-7). Hypertension 32: 496-502, 1998. (Pubitemid 28429139)
46. Zisman LS, Meixell GE, Bristow MR, Canver CC. Angiotensin-(1-7) formation in the intact human heart: in vivo dependence on Angiotensin II as substrate. Circulation 108: 1679-1681, 2002. (Pubitemid 37243653)